— Know what they know.
Not Investment Advice

LNTH NASDAQ

Lantheus Holdings, Inc.
1W: -2.3% 1M: +14.0% 3M: +27.9% YTD: +40.4% 1Y: +23.0% 3Y: -3.0% 5Y: +347.3%
$103.00
+8.53 (+9.03%)
 
Weekly Expected Move ±5.1%
$84 $89 $94 $99 $103
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Buy · Power 70 · $6.7B mcap · 58M float · 1.71% daily turnover · Short 49% of daily vol

Cash Flow Trends

Operating Cash Flow
$390M -28.4% ▼
5Y CAGR: +88.5%
Capital Expenditures
$36M +30.1% ▲
5Y CAGR: +23.7%
Free Cash Flow
$354M -28.2% ▼
5Y CAGR: +146.1%
Dividends Paid
$0 +0.0% ▲
Buybacks
$300M -200.0% ▼
Net Change in Cash
-$554M -377.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$71M$28M$327M$312M$234M
Depreciation & Amort.$42M$48M$60M$65M$70M
Stock-Based Comp.$16M$29M$51M$76M$0
Change in Working Capital-$15M-$75M-$171M$2M-$44M
Other Non-Cash Items$78M$303M$95M$114M$109M
Operating Cash Flow$54M$282M$305M$545M$390M
— Investing Activities —
Capital Expenditures-$12M-$18M-$47M-$80M-$42M
Acquisitions (Net)$0$0$0-$81M-$576M
Investment Purchases$0$0$0-$83M-$10M
Investment Sales$0$0$0$0$0
Other Investing$16M-$258M$52M$18M$0
Investing Cash Flow$4M-$277M$6M-$226M-$627M
— Financing Activities —
Net Debt Issuance-$43M$382M-$717K-$318K-$1M
Stock Repurchased$0-$75M$0-$100M-$300M
Dividends Paid$0$0$0$0$0
Other Financing$3M$3M-$14M-$22M-$26M
Financing Cash Flow-$39M$312M-$13M-$119M-$317M
Net Change in Cash$18M$317M$298M$199M-$554M
Cash End of Period$101M$417M$715M$914M$361M
Free Cash Flow$42M$263M$259M$493M$354M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms